Condition

Thrombocytopenia, Neonatal Alloimmune clinical trials and research

• 2Clinical trials
• 18Countries

All recruiting trials (2)

• Evaluating nipocalimab and IVIG for preventing fetal and neonatal thrombocytopenia

  This study is testing if a new treatment called nipocalimab can help pregnant women with a history of fetal and neonatal thrombocytopenia keep their babies' platelet levels safe compared to standard treatment with IVIG.

  Recruiting at 37 sites Phase 3 Janssen Research & Development, LLC · Birmingham, Alabama and 37 other locations · NCT06533098

• Evaluating nipocalimab for preventing fetal and neonatal alloimmune thrombocytopenia

  This study is testing whether nipocalimab can help pregnant women with a history of a blood condition called fetal and neonatal alloimmune thrombocytopenia prevent serious problems for their babies.

  Recruiting at 6 sites Phase 3 Janssen Research & Development, LLC · Leuven and 20 other locations · NCT06449651

Related topics

Quick answers

How many Thrombocytopenia, Neonatal Alloimmune clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 18 countries. The most sites are in Belgium (2 trials), Israel (2 trials), Italy (2 trials), Slovakia (2 trials), Slovenia (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →